BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 104 filers reported holding BLUEBIRD BIO INC in Q2 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $14,318,000 | -22.3% | 167,367 | +53.0% | 2.06% | +11.0% |
| Q2 2015 | $18,417,000 | -23.9% | 109,383 | -45.4% | 1.85% | -22.9% |
| Q1 2015 | $24,200,000 | -47.9% | 200,379 | -60.4% | 2.40% | -51.8% |
| Q4 2014 | $46,422,000 | +77.5% | 506,122 | -30.6% | 4.99% | +61.5% |
| Q3 2014 | $26,150,000 | +34.8% | 728,812 | +44.9% | 3.09% | +57.6% |
| Q2 2014 | $19,403,000 | +82.5% | 503,062 | +7.6% | 1.96% | +157.3% |
| Q1 2014 | $10,629,000 | +8.4% | 467,418 | 0.0% | 0.76% | -33.3% |
| Q4 2013 | $9,806,000 | -22.2% | 467,418 | 0.0% | 1.14% | -13.2% |
| Q3 2013 | $12,602,000 | – | 467,418 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |